Pharmaceuticals

Drug Development Weight Loss Drugs Clinical Trials Market Competition Drug Pricing Biotechnology Acquisitions Vaccine Development Drug Sales Oncology

6 ARTICLES

3d ago

GSK Secures $370 Million After CureVac US Patent Settlement

The settlement grants BioNTech and Pfizer licences for mRNA Covid and influenza vaccines with a $130 million contingent payment tied to BioNTech’s planned takeover of CureVac

9 ARTICLES

last wk.

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

3 ARTICLES

2w ago

Wegovy Prescriptions Surge as FDA Ban Cuts Into Copycats

6 ARTICLES

2w ago

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

5 ARTICLES

2w ago

BNSF Engages Goldman Sachs to Explore Rival Railroad Takeover

11 ARTICLES

2w ago

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request

16 ARTICLES

3w ago

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

9 ARTICLES

3w ago

PepsiCo Beats Q2 Forecasts, Narrows Full-Year EPS Decline Outlook

4 ARTICLES

4w ago

Walgreens Shareholders Approve $10 Billion Sale to Sycamore Partners

6 ARTICLES

4w ago

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

10 ARTICLES

last mo.

AstraZeneca CEO Considers Shifting Primary Listing to U.S.

12 ARTICLES

last mo.

Apollo Hospitals Board Approves Demerger of Pharmacy and Digital Health Businesses

3 ARTICLES

last mo.

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio

8 ARTICLES

last mo.

Top Indian Firms Set June 26 Cutoff for FY25 Dividend Eligibility

Particle.news

Pharmaceuticals

GSK Secures $370 Million After CureVac US Patent Settlement

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

CVS Health Tops Q2 Forecasts, Lifts 2025 Earnings Guidance

Novo Nordisk Cuts 2025 Outlook and Names New CEO as Shares Plunge

FDA Lifts Hold on Elevidys Shipments to Ambulatory Duchenne Patients

Merck Launches $3 Billion Cost-Optimization Program Following Q2 Revenue Miss

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

Wegovy Prescriptions Surge as FDA Ban Cuts Into Copycats

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Never miss stories about

Pharmaceuticals

BNSF Engages Goldman Sachs to Explore Rival Railroad Takeover

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

PepsiCo Beats Q2 Forecasts, Narrows Full-Year EPS Decline Outlook

Walgreens Shareholders Approve $10 Billion Sale to Sycamore Partners

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

AstraZeneca CEO Considers Shifting Primary Listing to U.S.

Apollo Hospitals Board Approves Demerger of Pharmacy and Digital Health Businesses

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio

Top Indian Firms Set June 26 Cutoff for FY25 Dividend Eligibility

Never miss stories about

Pharmaceuticals